Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Randomized Controlled Trial
100%
Placebo
34%
Lung Cancer
33%
Quality of Life
24%
Health Care Cost
23%
Oral
19%
Supplementation
18%
Sarcopenia
18%
Breast Cancer
18%
Primary Health Care
17%
Arm
16%
Hepatitis C
15%
Magnetic Resonance Imaging
15%
Lung
15%
Autoantibodies
15%
Chronic Kidney Disease
15%
Lung Cancer Screening
14%
Leucine
14%
Adverse Event
13%
Sodium Bicarbonate
13%
Myotonic Dystrophy
13%
Weight Management
13%
Physical Performance
12%
Treatment Effect
12%
Blood Pressure
11%
Vitamin D
11%
Atherosclerotic Plaque
11%
ACE Inhibitor
11%
Diseases
11%
Hepatitis C Virus
11%
Cardiovascular Disease
11%
Perindopril
10%
Infection
10%
Acidosis
9%
Cardiac Magnetic Resonance Imaging
9%
Clinical Trial
9%
Computer Assisted Tomography
9%
Arterial Stiffness
9%
Cognitive Behavioral Therapy
9%
Left Ventricular Hypertrophy
9%
Image Guided Biopsy
9%
Prostate Cancer
9%
Systolic Hypertension
9%
Breast Screening
9%
Lung Nodule
9%
Nicotine Withdrawal
9%
Adolescence
9%
Biopsy Technique
8%
Body Mass Index
8%
Volunteer
8%
Clinician
8%
Intention-to-Treat Analysis
8%
Physical Activity
7%
Shear Wave Elastography
7%
Antiviral Therapy
7%
Prevalence
7%
Cross Sectional Study
7%
Drug Use
7%
Colecalciferol
7%
25 Hydroxyvitamin D
6%
Vitamin K2
6%
Early Diagnosis
6%
Reinfection
5%
COVID-19
5%
Obesity
5%
Low Drug Dose
5%
Disease Severity
5%
Tumor Antigen
5%
Injection
5%
Odds Ratio
5%
Interferon
5%
Allele
5%
Keyphrases
Randomized Controlled Trial
64%
Older People
26%
People Who Inject Drugs
24%
Hepatitis C
24%
Sarcopenia
22%
Hepatitis C Virus
22%
Scotland
20%
Placebo
20%
Methylphenidate
18%
Tayside
17%
Perindopril
16%
Muscle Mass
16%
Physical Performance
14%
Blood Pressure
13%
Cluster Randomized Trial
13%
Oral Sodium Bicarbonate
12%
Angiotensin-converting Enzyme Inhibitor (ACEi)
12%
Pharmacy
12%
95% Confidence Interval
11%
Short Physical Performance Battery
11%
Quality of Life
11%
Clinical Efficacy
11%
Older Patients
10%
Cost-effectiveness
10%
Physical Function
10%
Treatment Effect
9%
Meta-analysis
9%
Opioid Substitution Treatment
9%
Antiviral Treatment
9%
Bicarbonate
9%
Isolated Systolic Hypertension
9%
Real-world Outcomes
9%
Genotype
8%
Hepatitis C Virus Treatment
8%
Adverse Events
8%
Intervention Group
8%
Leucine
7%
Community Pharmacy
7%
HCV Treatment
7%
Opioid Agonist Treatment
7%
Randomized Placebo-controlled Trial
7%
Between-groups Differences
7%
Arterial Stiffness
7%
Vitamin K2
6%
SVR12
6%
Sustained Virological Response
6%
Point-of-care
6%
Hepatitis C Virus RNA
6%
Vitamin D Supplementation
6%
Postural Sway
6%
Chronic Kidney Disease
6%
Clinically Significant
6%
Direct-acting Antivirals
6%
Clinical Outcomes
6%
Attention Deficit Hyperactivity Disorder
6%
Breast Cancer
6%
RNA Testing
5%
Direct-acting Antiviral Treatment
5%
Prison
5%
Left Ventricular Hypertrophy
5%
6-minute Walk Distance (6MWD)
5%
Asthma
5%
Allopurinol
5%
Vitamin D
5%
Orthostatic Hypotension
5%
Rehabilitation after Stroke
5%
Randomised Controlled Feasibility Trial
5%
UK Population
5%
Body Composition
5%
Incidence Rate
5%
Kidney Disease Progression
5%
Injecting Equipment
5%
Acidosis
5%
Quality-adjusted Life Years
5%
Treatment Regimen
5%
Directly Observed Therapy
5%
Economic Evaluation
5%
Vascular Stiffness
5%
Methylphenidate Treatment
5%
High Dose
5%
Nursing and Health Professions
Hepatitis C
31%
Placebo
23%
Lung Cancer
22%
Confidence Interval
21%
Quality of Life
20%
Cancer Screening
18%
Physical Function
15%
Feasibility Study
14%
Myotonic Dystrophy
13%
Sarcopenia
13%
Youth
13%
Cognitive Behavioral Therapy
13%
Colorectal Carcinoma
13%
Physical Activity
12%
Muscle Mass
12%
Cerebrovascular Accident
12%
Antiviral Therapy
12%
Primary Health Care
12%
Primary Medical Care
12%
Adverse Event
11%
Walking Distance
11%
Perindopril
10%
Chronic Kidney Failure
10%
Muscle Function
9%
Nurse
9%
Asthma
9%
Massage
9%
Neurogenic Bowel
9%
Lung Nodule
9%
Stroke Rehabilitation
9%
Breast Cancer
9%
Economic and Social Development
8%
Weight Management
8%
Intention to Treat Analysis
8%
Diseases
8%
Qualitative Research
8%
Biological Marker
8%
Clinical Outcome
7%
Multiple Sclerosis
7%
Randomization
7%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Cancer ELISA Kit
7%
Vitamin K Group
6%
Creatine Phosphate
6%
Sustained Virologic Response
6%
Systematic Review
6%
Obesity
6%
Virus RNA
6%
Supplementation
6%
Care Pathway
6%
Meta Analysis
6%
Computer Assisted Tomography
6%
Leucine
6%
Kinesiotherapy
6%
Clinical Effectiveness
6%
Farnoquinone
6%
Self-Efficacy
5%
Orthosis
5%
Functional Disease
5%
Education
5%
Community Care
5%
Allopurinol
5%
Qualitative Study
5%
Odds Ratio
5%
Dicarbonate
5%
Exercise
5%
Body Mass
5%
Prevalence
5%
Autoantibodies
5%
Phosphorus Nuclear Magnetic Resonance
5%
Volunteer
5%
Malignant Neoplasm
5%